Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

AGILON HEALTH, INC.

(AGL)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

agilon health : Wells Fargo Adjusts Price Target on Agilon Health to $44 From $38, Maintains Overweight Rating

06/03/2021 | 09:26am EDT


ę MT Newswires 2021
All news about AGILON HEALTH, INC.
09/22AGILON HEALTH : October 2021 Investor Presentation
PU
09/20AGILON HEALTH, INC.(NYSE : AGL) added to S&P Health Care Services Select Industry Index
CI
09/20AGILON HEALTH, INC.(NYSE : AGL) added to S&P Global BMI Index
CI
09/15INSIDER SELL : Agilon Health
MT
09/10AGILON HEALTH : Cowen Starts agilon health at Outperform with $44 Price Target
MT
09/10AGILON HEALTH : Prices Secondary Share Offering At $30 Per Share
MT
09/09AGILON HEALTH : Announces Pricing of Secondary Offering
BU
09/07AGILON HEALTH : Stockholders to Offer 17 Million Common Shares in Secondary Offering
MT
09/07AGILON HEALTH : Announces Secondary Offering
BU
09/05AGILON HEALTH : September 2021 Investor Presentation
PU
More news
Analyst Recommendations on AGILON HEALTH, INC.
More recommendations
Financials (USD)
Sales 2021 1 803 M - -
Net income 2021 -404 M - -
Net cash 2021 1 131 M - -
P/E ratio 2021 -27,8x
Yield 2021 -
Capitalization 10 984 M 10 984 M -
EV / Sales 2021 5,47x
EV / Sales 2022 3,97x
Nbr of Employees 550
Free-Float 98,5%
Chart AGILON HEALTH, INC.
Duration : Period :
agilon health, inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AGILON HEALTH, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Last Close Price 28,10 $
Average target price 42,86 $
Spread / Average Target 52,5%
EPS Revisions
Managers and Directors
Steven J. Sell President, Chief Executive Officer & Director
Timothy S. Bensley Chief Financial Officer
Ronald A. Williams Chairman
Benjamin Kornitzer Chief Medical & Quality Officer
Girish Venkatachaliah Chief Technology Officer
Sector and Competitors